stocks logo

DRTS

Alpha Tau Medical Ltd
$
3.260
-0.02(-0.610%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.330
Open
3.290
VWAP
3.22
Vol
40.60K
Mkt Cap
277.24M
Low
3.130
Amount
130.91K
EV/EBITDA(TTM)
--
Total Shares
69.80M
EV
203.57M
EV/OCF(TTM)
--
P/S(TTM)
--
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Show More
Financial AI Agent

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
--
--
-0.123
+2.78%
--
--
-0.128
-1.72%
--
--
-0.117
+17.13%
Estimates Revision
The market is revising No Change the revenue expectations for Alpha Tau Medical Ltd. (DRTS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 5.16%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+3.94%
In Past 3 Month
Stock Price
Go Up
up Image
+5.16%
In Past 3 Month
2 Analyst Rating
Wall Street analysts forecast DRTS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DRTS is 7.00 USD with a low forecast of 5.00 USD and a high forecast of 9.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.260
sliders
Low
5.00
Averages
7.00
High
9.00
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$9
2025-03-17
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$9
2024-11-22
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$9
2024-10-23
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$9
2024-10-11
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$9
2024-08-20
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Alpha Tau Medical Ltd (DRTS.O) is -6.57, compared to its 5-year average forward P/E of -13.44. For a more detailed relative valuation and DCF analysis to assess Alpha Tau Medical Ltd 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-13.44
Current PE
-6.57
Overvalued PE
-1.43
Undervalued PE
-25.45

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-4.05
Current EV/EBITDA
-8.74
Overvalued EV/EBITDA
0.08
Undervalued EV/EBITDA
-8.17

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
413.56
Current PS
607.32
Overvalued PS
1200.47
Undervalued PS
-373.34
AI Stock Picker

Financials

Annual
Quarterly
FY2025Q1
YoY :
+10.49%
-9.31M
Operating Profit
FY2025Q1
YoY :
+8.90%
-8.69M
Net Income after Tax
FY2025Q1
YoY :
+9.09%
-0.12
EPS - Diluted
FY2022Q2
YoY :
+221.47%
-9.12M
Free Cash Flow

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Intellectia AI SwingMax

DRTS News & Events

Events Timeline

2025-08-11 (ET)
2025-08-11
16:25:33
Alpha Tau reports 1H EPS (25c) vs. (22c) last year
select
2025-05-19 (ET)
2025-05-19
16:03:19
Alpha Tau reports Q1 EPS (12c), consensus (13c)
select
2025-04-28 (ET)
2025-04-28
09:05:26
Alpha Tau enters strategic marketing alliance with Oramed
select
Sign Up For More Events

News

9.5
05-19Newsfilter
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
1.0
05-06Newsfilter
Alpha Tau to Participate in May Investor Conferences
8.5
04-28Newsfilter
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Sign Up For More News

FAQ

arrow icon

What is Alpha Tau Medical Ltd (DRTS) stock price today?

The current price of DRTS is 3.26 USD — it has decreased -0.61 % in the last trading day.

arrow icon

What is Alpha Tau Medical Ltd (DRTS)'s business?

arrow icon

What is the price predicton of DRTS Stock?

arrow icon

What is Alpha Tau Medical Ltd (DRTS)'s revenue for the last quarter?

arrow icon

What is Alpha Tau Medical Ltd (DRTS)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Alpha Tau Medical Ltd (DRTS)'s fundamentals?

arrow icon

How many employees does Alpha Tau Medical Ltd (DRTS). have?

arrow icon

What is Alpha Tau Medical Ltd (DRTS) market cap?